Metabolic Syndrome Symptoms and the Five Criteria That Define It

The five criteria (three of five confirms it)

Metabolic syndrome is not diagnosed from one “bad” number. It means several risk signals are showing up in the body at the same time: more abdominal fat, insulin resistance, blood-pressure strain, and an atherogenic lipid pattern. In the commonly used harmonized definition, any three of the five criteria below are enough to meet the definition; waist size matters, but it is not required to be the “main” or mandatory criterion (IDF/AHA/NHLBI harmonized criteria, Alberti et al., 2009).

Diagnosis requires three or more of these five criteria present together, at the thresholds defined by the guideline being used. ATP III originally used the “any 3 of 5” structure; the 2005 AHA/NHLBI update kept that structure while lowering the fasting-glucose threshold to align with impaired fasting glucose, and the 2009 IDF/AHA/NHLBI harmonized statement confirmed that three abnormal findings out of five qualify a person for metabolic syndrome (AHA/NHLBI Scientific Statement, Grundy et al., 2005).

Why metabolic syndrome is usually "silent"

The honest headline of this page is that metabolic syndrome typically doesn’t announce itself with symptoms you can feel. You can’t sense a triglyceride level. You usually can’t feel low HDL cholesterol, or blood pressure that has crept up, or fasting glucose that is just high enough to matter. That’s why metabolic syndrome is diagnosed by measurement: a waist measurement, a blood-pressure reading, and blood tests such as fasting glucose and lipid testing. In other words, the five diagnostic items are mostly signs — findings your clinician can measure — not symptoms your body reliably reports (American Heart Association: Symptoms and Diagnosis of Metabolic Syndrome).

That silence is the risk. If you wait until you “feel metabolic syndrome,” you may miss the window when the pattern is easiest to catch: abdominal fat, rising blood pressure, higher triglycerides, lower HDL cholesterol, and higher fasting blood sugar clustering together before they become diabetes, heart disease, or stroke. Some people with high blood sugar do notice clues like unusual thirst, more frequent urination, fatigue, or blurred vision, but those are not guaranteed — and they often show up later than the lab changes (NHLBI: Metabolic Syndrome — Symptoms).

The one sign a person may notice directly is central obesity: more weight carried around the abdomen, sometimes described as a larger waist relative to the hips. Even here, appearance is not enough. Clinically, this is measured as waist circumference because the concern is not just body size; it’s the amount and behavior of fat stored deep in the abdomen. Visceral fat sits around internal organs and is more strongly tied to insulin resistance and metabolic risk than fat stored just under the skin (Cleveland Clinic: Metabolic Syndrome).

Visceral adiposity is also central to the newer cardiovascular-kidney-metabolic framework, which links abdominal fat biology with insulin resistance, inflammation, vascular dysfunction, and downstream heart, kidney, and metabolic disease — supporting why waist and visceral fat, not just body size, is one of the defining signs (Frontiers in Endocrinology, 2025).

When you do notice something: symptoms of the components

When symptoms show up, they usually aren’t “metabolic syndrome” announcing itself. They’re one part of the cluster getting far enough out of range to affect how you feel. Very high blood sugar — toward or into the diabetes range — can make you unusually thirsty, send you to the bathroom more often, blur your vision, and leave you feeling wiped out. Those sensations happen because excess glucose changes fluid balance, pulls water into urine, and can affect the lenses and small vessels in the eyes (CDC: Diabetes Signs and Symptoms).

Blood pressure is different: even when it is high, it usually gives you no reliable warning signal. That is why the cuff reading matters more than how you feel. If blood pressure is very high and comes with a severe headache, chest pain, shortness of breath, weakness, numbness, vision changes, trouble speaking, or any other new concerning symptom, treat it as an emergency and seek immediate medical attention rather than “wait and see” (American Heart Association: Symptoms of High Blood Pressure).

Insulin resistance can sometimes leave a visible clue on the skin: acanthosis nigricans — darker, thicker, velvety patches in body folds such as the neck, armpits, or groin. It is a sign to ask about blood sugar and insulin-resistance risk, not a stand-alone diagnosis (MedlinePlus: Acanthosis nigricans). Feeling generally low-energy can also travel with high blood sugar, poor sleep, stress, medications, anemia, thyroid problems, depression, and dozens of other things, so fatigue alone does not confirm metabolic syndrome (CDC: Diabetes Signs and Symptoms).

The key framing: these are symptoms of advanced components, not of metabolic syndrome as a single “felt” illness. Their absence does not mean you’re in the clear. Metabolic syndrome is defined by measured risk factors — waist circumference, triglycerides, HDL cholesterol, blood pressure, and fasting blood glucose — and is diagnosed when enough of those numbers cluster together. Screening is what finds it (American Heart Association: Symptoms and Diagnosis of Metabolic Syndrome).

How the criteria are actually measured

You cannot self-diagnose metabolic syndrome from how you feel. The criteria are physical measurements and lab values, so the useful move is to know what will be checked and show up prepared.

• Waist circumference is measured with a tape, not guessed from clothing size or weight. The exact landmark can vary by protocol: NHLBI patient guidance describes placing the tape around your middle just above the hipbones, while WHO/IDF-style protocols use the midpoint between the lowest rib and the top of the iliac crest. Either way, the point is consistency: stand upright, keep the tape level and snug without compressing skin, and measure at the end of a normal breath (NHLBI: Healthy Weight).

• Fasting glucose, triglycerides, and HDL cholesterol are measured from a blood sample, usually as part of a glucose test and lipid panel. If your clinician orders fasting labs, you’ll typically be asked not to eat or drink anything except water for 8–12 hours; triglyceride testing may specifically require about 9–12 hours. Ask the lab or clinician which tests need fasting, because not every glucose or cholesterol test uses the same preparation (MedlinePlus: Fasting for a Blood Test).

• Blood pressure is measured with a cuff, and technique matters because posture, talking, caffeine, exercise, bladder fullness, and cuff size can all shift the number. For the cleanest reading, use a validated upper-arm cuff, sit with your back supported and feet flat, rest quietly for about five minutes, keep the cuffed arm supported at heart level, and take at least two readings about a minute apart rather than treating one number as the whole story (American Heart Association: Monitoring Your Blood Pressure at Home).

Welltory does not measure any of these five criteria. What a wearable and app can surface is lifestyle context — resting heart rate, HRV, sleep regularity, and daily activity — which may help you understand the strain your body is under day to day, but it is not a metabolic syndrome criterion and cannot replace waist measurement, blood pressure, or bloodwork. Bring your data and get the labs.

What our own data shows

Weight — specifically a higher BMI — is the one component of metabolic syndrome you can sometimes see, and in Welltory's own data it comes with a heavier day-to-day physiological load. This isn't a diagnostic criterion; it's exactly the kind of lifestyle strain a wearable can surface.

We compared 1,169 Welltory users with a self-reported BMI ≥ 30 against 2,976 with a BMI < 30 (users with quality wearable data over ≥ 30 days, matched on age and number of coexisting conditions):

Put simply: on average, users with a BMI ≥ 30 wake up with less energy (78 vs 87 out of 100) and accumulate more stress by the end of the day (55 vs 45) — even at the same age and with the same number of coexisting conditions. These gaps also hold when we compare people who take a similar number of daily steps, so they are not explained by lower activity alone.

Sleep, recovery, activity, and stress all show up in the data — and they respond to lifestyle changes sooner than weight or lab results do. That makes them worth watching: they show what your body is responding to, and where small steps make a visible difference. Gentle, manageable movement often helps here earlier than intense effort.

The numbers behind this.

Observational data based on self-reported height and weight; BMI ≥ 30 (n = 1,169) vs BMI < 30 (n = 2,976), users with quality wearable data over ≥ 30 days. Differences hold within every level of coexisting-condition count, within the 46–65 age band, and within matched activity levels — so they are not explained by comorbidity, age, or lower activity. More heavily burdened users were less likely to sustain long-term tracking, so these differences are more likely understated than overstated. This is an association, not causation: the data does not show that BMI causes these changes. Welltory tracks and surfaces these signals but does not diagnose. All figures are reported as anonymized, aggregated data; no individual user is identifiable.

Why "three of five" and why it matters early

A single borderline number can be a warning light, not the syndrome itself. Three of five is the cutoff because metabolic syndrome is meant to identify a pattern: abdominal fat, blood pressure, blood sugar, triglycerides, and HDL cholesterol moving in the same unhealthy direction. NHLBI describes metabolic syndrome as a group of conditions that together raise the risk of coronary heart disease, diabetes, stroke, and other serious problems; AHA uses the same practical rule — diagnosis when three or more of the defining conditions are present (NHLBI: Metabolic Syndrome).

That matters because these numbers are not random strangers on a lab report. Visceral fat can make your tissues less responsive to insulin. Insulin resistance can push glucose up, worsen triglycerides, lower protective HDL, and travel with higher blood pressure. ATP III framed metabolic syndrome as a risk enhancer and emphasized its root causes — overweight/obesity and physical inactivity — because changing those drivers can improve several components at once, not just one isolated value (NCEP ATP III Final Report, NHLBI).

So if you have one or two abnormal or borderline results, you may not meet the formal metabolic syndrome criteria yet. But it is still an early signal worth acting on. This is the window where activity, diet quality, sleep regularity, and weight distribution can still change the trajectory before the pattern becomes more entrenched. Monitoring also matters: the diagnosis is not based on how you feel, but on whether enough measured signs cluster over time (American Heart Association: Symptoms and Diagnosis of Metabolic Syndrome).

Large datasets show that this clustering is real clinically, not just a tidy checklist. In a Korean national health-screening database of 6,891,400 adults aged 20–40 years, those who later developed a rare cerebrovascular condition had a worse baseline metabolic profile: as the authors reported, “These participants exhibited significantly poorer baseline metabolic profiles, including a higher body mass index and a higher prevalence of diabetes, hypertension, and dyslipidemia (all P < 0.0001).” Use that finding narrowly: it supports the idea that metabolic problems cluster and mark a worse profile, not that metabolic syndrome commonly causes that rare outcome (Lee et al., *J Am Heart Assoc*, 2025).

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data